Related Experiment Videos
Mammalian cell expression of dimeric small immune proteins (SIP)
1International Centre for Genetic Engineering and Biotechnology, Area Science Park, Trieste, Italy.
Protein Engineering
|June 1, 1997
Summary
We developed bivalent small immune proteins (SIP) using antibody fragments. These novel engineered proteins effectively form dimers, retaining antigen specificity and comparable functional affinity for potential therapeutic applications.
Area of Science:
- Protein Engineering
- Immunotechnology
- Biochemistry
Background:
- Small immune proteins (SIP) are engineered proteins based on antibody fragments.
- Developing novel protein constructs with enhanced stability and functionality is crucial in immunotechnology.
Purpose of the Study:
- To design and express bivalent small immune proteins (SIP) based on scFv fragments.
- To evaluate the assembly, secretion, stability, and functional affinity of different SIP constructs.
Main Methods:
- Genetic engineering of three distinct SIP constructs utilizing scFv fragments and human IgG1 CH3 domains.
- Expression of SIPs in mammalian cells.
- Analysis of SIP dimerization, antigen specificity (Western blotting), and functional affinity (ELISA).
Main Results:
- Successfully designed and expressed three bivalent SIP variants.
- One construct featured a disulfide bond for enhanced stability.
- All SIPs formed dimers, maintained antigenic specificity, and exhibited comparable functional affinity (avidity).
Conclusions:
- Bivalent small immune proteins (SIP) can be efficiently engineered and expressed.
- The designed SIP constructs demonstrate stable dimerization and retained functional properties.
- These findings support the potential of SIPs as versatile tools in antibody-based therapies and diagnostics.